NCT04459364View on ClinicalTrials.gov

The Prevalence of Pulmonary Hypertension in Patients With COVID-19.

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 7, 2020

Study Completion Date

July 15, 2020

Conditions
Hypertension, PulmonaryRight Ventricular OverloadCOVID
Trial Locations (1)

17176

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Attgeno AB

INDUSTRY

NCT04459364 - The Prevalence of Pulmonary Hypertension in Patients With COVID-19. | Biotech Hunter | Biotech Hunter